LCO No. 2320 1 of 1
General Assembly Proposed Bill No. 5714
January Session, 2025
LCO No. 2320
Referred to Committee on PUBLIC HEALTH
Introduced by:
REP. ANDERSON, 62nd Dist.
AN ACT REQUIRING THE PROVISION OF WRITTEN INFORMATION
BY PHARMACISTS CONCERNING THE EFFECTS OF MIFEPRISTONE
WHEN DISPENSING TO A PATIENT.
Be it enacted by the Senate and House of Representatives in General
Assembly convened:
That the general statutes be amended to require pharmacists that are 1
dispensing mifepristone to a patient for the purposes of terminating a 2
pregnancy to provide written information that its effects may, in some 3
cases, be reversed if the patient decides to continue with the pregnancy 4
and seeks reversal treatment in a timely manner. 5
Statement of Purpose:
To protect reproductive rights in cases where a woman decides to
continue with a pregnancy.